These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 15232748)

  • 1. [Addiction characteristics as prognostic factors in opiate dependence treated with naltrexone].
    Madoz-Gúrpide A; Barbudo del Cura E; Leira Sanmartín M; Navio Acosta M; Villoria Borrego L; Ochoa Mangado E
    Actas Esp Psiquiatr; 2004; 32(4):199-210. PubMed ID: 15232748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Alcohol consumption in opioid-dependence patients in treatment with naltrexone].
    Ochoa Mangado E; Arias Horcajadas F
    Actas Esp Psiquiatr; 2000; 28(4):239-49. PubMed ID: 11116795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Gender differences in the treatment of the opiate dependence with naltrexone].
    Ochoa E; Madoz-Gúrpide A; Salvador E
    Actas Esp Psiquiatr; 2008; 36(4):197-204. PubMed ID: 18461494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What you need to know: addiction--prescribing naltrexone.
    Yeo BK
    Singapore Med J; 1997 Feb; 38(2):92-3. PubMed ID: 9269372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pilot study to assess the impact of naltrexone implant on accidental opiate overdose in 'high-risk' adolescent heroin users.
    Hulse GK; Tait RJ
    Addict Biol; 2003 Sep; 8(3):337-42. PubMed ID: 13129836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opiate addiction in China: current situation and treatments.
    Tang YL; Zhao D; Zhao C; Cubells JF
    Addiction; 2006 May; 101(5):657-65. PubMed ID: 16669899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving clinical outcomes in treating heroin dependence: randomized, controlled trial of oral or implant naltrexone.
    Hulse GK; Morris N; Arnold-Reed D; Tait RJ
    Arch Gen Psychiatry; 2009 Oct; 66(10):1108-15. PubMed ID: 19805701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Limited role of naltrexone in the treatment of opiate addiction].
    van Brussel GH
    Ned Tijdschr Geneeskd; 2001 Jul; 145(30):1452-6. PubMed ID: 11503313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Opiate dependence users profile. A decade review].
    Madoz-Gúrpide A; Ochoa E
    Actas Esp Psiquiatr; 2003; 31(5):263-71. PubMed ID: 14557951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultra-rapid opiate detoxification followed by nine months of naltrexone maintenance therapy in Iran.
    Naderi-Heiden A; Naderi A; Naderi MM; Rahmani-Didar F; Salimi AR; Gleiss A; Kasper S; Frey R
    Pharmacopsychiatry; 2010 Jun; 43(4):130-7. PubMed ID: 20101570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Naltrexone and prevention of opiate dependence relapse. An Italian experience].
    Cibin M; Gentile N; Ferri M; Gallimberti L
    Minerva Psichiatr; 1989; 30(2):93-8. PubMed ID: 2779401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing drug-related hospital morbidity following heroin dependence treatment with methadone maintenance or naltrexone implantation.
    Ngo HT; Tait RJ; Hulse GK
    Arch Gen Psychiatry; 2008 Apr; 65(4):457-65. PubMed ID: 18391134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mental health outcomes following naltrexone implant treatment for heroin-dependence.
    Ngo HT; Tait RJ; Arnold-Reed DE; Hulse GK
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):605-12. PubMed ID: 17229510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of mental health hospital admissions in a cohort of heroin users prior to and after rapid opiate detoxification and oral naltrexone maintenance.
    Arnold-Reed DE; O'Neil P; Holman CD; Bulsara MK; Rodiguez C; Gawthorne G; Tait RJ; Hulse GK
    Am J Drug Alcohol Abuse; 2007; 33(5):655-64. PubMed ID: 17891658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Detoxification treatment with naltrexone in opiate dependence].
    Ochoa Mangado E; López-Ibor Aliño JJ; Pérez de los Cobos Peris JC; Cebollada Gracia A
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1992; 20(5):215-29. PubMed ID: 1462806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood morphine levels in naltrexone-exposed compared to non-naltrexone-exposed fatal heroin overdoses.
    Arnold-Reed DE; Hulse GK; Hansson RC; Murray SD; O'Neil G; Basso MR; Holman CD
    Addict Biol; 2003 Sep; 8(3):343-50. PubMed ID: 13129837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naltrexone implants can completely prevent early (1-month) relapse after opiate detoxification: a pilot study of two cohorts totalling 101 patients with a note on naltrexone blood levels.
    Foster J; Brewer C; Steele T
    Addict Biol; 2003 Jun; 8(2):211-7. PubMed ID: 12850780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naltrexone with or without fluoxetine for preventing relapse to heroin addiction in St. Petersburg, Russia.
    Krupitsky EM; Zvartau EE; Masalov DV; Tsoy MV; Burakov AM; Egorova VY; Didenko TY; Romanova TN; Ivanova EB; Bespalov AY; Verbitskaya EV; Neznanov NG; Grinenko AY; O'Brien CP; Woody GE
    J Subst Abuse Treat; 2006 Dec; 31(4):319-28. PubMed ID: 17084785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Naltrexone--prevention of recurrence in narcotic dependence and in alcoholism].
    Poser W; Ehrenreich H
    Internist (Berl); 1996 Oct; 37(10):1061-7; discussion 1067. PubMed ID: 9019453
    [No Abstract]   [Full Text] [Related]  

  • 20. Does naltrexone affect craving in abstinent opioid-dependent patients?
    Dijkstra BA; De Jong CA; Bluschke SM; Krabbe PF; van der Staak CP
    Addict Biol; 2007 Jun; 12(2):176-82. PubMed ID: 17508990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.